Brief: Exopharm Gains U.S. Patent Enabling Commercial Production Of Exosome Medicines
Dec 22 (Reuters) - Exopharm Ltd EX1.AX :
* EXOPHARM GAINS US PATENT ENABLING COMMERCIAL PRODUCTION OF
EXOSOME MEDICINES
Source text for Eikon: ID:nPn4Scc1xa
Further company coverage: EX1.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entropy Neurodynamics
See all newsBrief: Entropy Neurodynamics Seeks Trading Halt
Brief: Entropy Neurodynamics Says Strategic Agreement Signed With CDMO Biocina
Brief: Entropy Neurodynamics Secures HREC Approval For Phase 1B/2A 8-Indication Basket Study Of TRP-8803
Brief: Entropy Neurodynamics Requests Trading Halt
Brief: Entropy Neurodynamics Seeks Trading Halt